[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342133-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342133-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","screening-for-prolinerich-protein-11-gene-expression-in-cervical-cancer-use-as-a-novel-diagnostic-biomarker-and-poor-prognostic-factor","Screening for proline‑rich protein 11 gene expression in cervical cancer - Use as a novel diagnostic biomarker and poor prognostic factor","","Cervical cancer is the fourth most common cancer affecting women worldwide and is often diagnosed late, leading to poor prognosis. The study evaluates proline‑rich protein 11 (Prr11) as a potential biomarker, noting that Prr11 expression is deregulated in multiple cancers yet remains insufficiently clarified for cervical cancer. Reverse transcription‑quantitative PCR quantified Prr11 mRNA in 100 tumor and adjacent normal tissue samples, then tested associations with clinicopathological variables and overall survival.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/screening-for-prolinerich-protein-11-gene-expression-in-cervical-cancer-use-as-a-novel-diagnostic-biomarker-and-poor-prognostic-factor/342133/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/screening-for-prolinerich-protein-11-gene-expression-in-cervical-cancer-use-as-a-novel-diagnostic-biomarker-and-poor-prognostic-factor/342133.png","ImageObject",300,407,{"name":42,"@type":43},"Seraphina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this study on Prr11 in cervical cancer?","Question",{"text":63,"@type":64},"To determine whether Prr11 gene expression can serve as a novel diagnostic biomarker and a poor prognostic factor in cervical cancer, and to characterize related clinicopathological features.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was Prr11 expression measured in cervical cancer tissues?",{"text":68,"@type":64},"Reverse transcription‑quantitative PCR (RT‑qPCR) was used to assess Prr11 mRNA expression levels in 100 cervical cancer samples and corresponding adjacent normal tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic performance did the study report for Prr11?",{"text":72,"@type":64},"Prr11 expression differentiated cancerous from normal cervical tissue with sensitivity of 88.75%, specificity of 100%, an AUC of 0.982, and a Youden index of 88.7%.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342133,1790445681,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":102,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","MEDICINE INtErNatIoNal 5: 3, 2025  \nScreening for proline‑rich protein 11 gene expression in cervical cancer: Use as a novel diagnostic biomarker and poor prognostic factor  \n1 1 1 1  \nKaoUtaraNoUar taDlaoUI , SoUKaYNa alaoUI SoSSE , IKRAM TIABI , MoUNa aQErroUt , aMal SoUIrI1,2 , MUSTAPHA BENHESSOU 1,3 and MoUlaY MUStaPHa ENNaJI1  \n1Research Team of Virology, Oncology and Biotechnologies, Laboratory of Virology, Oncology, Biosciences, Environment and  \nNew Energies, Faculty of Sciences and techniques Mohammedia, University Hassan II of Casablanca, Mohammedia 28806, 2  \nMorocco; research and Medical analysis laboratory of the royal Gendarmerie Fraternity of rabat, rabat 10080, Morocco; 3  \nFaculty of Medicine and Pharmacy of Casablanca, University Hassan II of Casablanca, Casablanca 20250, Morocco  \nreceived May 27, 2024; accepted october 21, 2024  \nDoI: 10. 3892/mi.2024.202  \nAbstract. Cervical cancer is the fourth most common typeof cancer affecting the female population worldwide, and it is associated with a late diagnosis and a poor prognosis. It is thus imperative to improve modern diagnostic methods by searching for novel tumor biomarkers, such as proline‑rich protein 11 (Prr11), the expression of which is deregulated in various types of cancer and participates in their cellular progression. However, the involvement of Prr11 in cervical cancer has not yet been fully elucidated. the present study thus aimed to investigate the expression of Prr11 in cervical cancer as a diagnostic and prognostic biomarker, and to char‑ acterize the associated clinicopathological features. For this purpose, reverse transcription‑quantitative PCr was used to assess the mrNa expression level of Prr11 in 100 cervical cancer and corresponding adjacent normal tissues. Statistical analysis was then performed to determine the association between Prr11 expression and the clinicopathological data of patients, and the overall survival rate of patients . the results revealed that Prr11 gene expression in cervical cancer tissues was significantly higher than that in corresponding normal adjacent tissues. No significant differences were found between Prr11 gene expression, age at diagnosis, FIGo stage, or histological type. Patients with a positive Prr11 expression  \nCorrespondence to: Professor Moulay Mustapha Ennaji, research Team of Virology, Oncology and Biotechnologies, Laboratory of Virology, Oncology, Biosciences, Environment and New Energies, Faculty of Sciences and techniques Mohammedia, University Hassan II of Casablanca, P.O. BOX 146, Quartier Yasmina, Mohammedia 28806, Morocco  \nE‑[mail: m.ennaji@yahoo.fr](mail: m.ennaji@yahoo.fr); [my.ennaji@univh2m.ma](my.ennaji@univh2m.ma); moulaymustapha.  \n[ennaji@fstm.ac.ma](ennaji@fstm.ac.ma)  \nKey words: proline‑rich protein 11, cervical cancer, quantitative PCr, biomarker, diagnosis, prognosis  \nhad a shorter survival rate (P=0.035) . as regards the diag‑ nostic value, the results demonstrated that Prr11 expression was able to differentiate cancerous from normal cervical tissue with a sensitivity of 88.75%, a specificity of 100%, an area under the curve of 0.982 and a Youden index of 88.7% . Thus, PRR11 satisfies the standard criteria to be applied in diagnosis. on the whole, the present study demonstrates that Prr11 is well‑expressed in cervical cancer tissues, is related to age and a poor prognosis, and may thus serve as a potential novel biomarker for cervical cancer diagnosis.  \nIntroduction  \namong the female malignancies, cervical cancer (1) is the fourth type of cancer and the second leading cause of cancer‑related mortality among the female population, with high incidence and mortality rates worldwide, with 604,127 (3 . 1%) new cases and 341,831 (4 . 1%) related deaths (1) . In addi‑ tion, CC is the leading cause of cancer‑related death among females in 36 low‑ and middle‑income countries (2) . this is mainly due to late detection and poor prognoses, which reduces the chances of curative sur","cbCaicwsWyV92C1M","https://ap.wps.com/l/cbCaicwsWyV92C1M","pdf",1645016,"English","# Abstract\n# Introduction\n## Background on cervical cancer and need for biomarkers\n## Prr11 as a candidate biomarker\n# Patients and methods","[{\"question\":\"What is the main goal of this study on Prr11 in cervical cancer?\",\"answer\":\"To determine whether Prr11 gene expression can serve as a novel diagnostic biomarker and a poor prognostic factor in cervical cancer, and to characterize related clinicopathological features.\"},{\"question\":\"How was Prr11 expression measured in cervical cancer tissues?\",\"answer\":\"Reverse transcription‑quantitative PCR (RT‑qPCR) was used to assess Prr11 mRNA expression levels in 100 cervical cancer samples and corresponding adjacent normal tissues.\"},{\"question\":\"What diagnostic performance did the study report for Prr11?\",\"answer\":\"Prr11 expression differentiated cancerous from normal cervical tissue with sensitivity of 88.75%, specificity of 100%, an AUC of 0.982, and a Youden index of 88.7%.\"}]","Screening for proline‑rich protein 11 gene expression in cervical cancer - Use as a novel diagnostic biomarker and poor prognostic factor | PDF",1790045430,15,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/596727c1898f662d71faa7f13617867f.webp",983,1357,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3397a9315142fc24056bde9cdca86f4.webp",982,1356,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca56c5473c206b37159a9c0583c61719.webp",981,1354,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ce8b4b914a3dfab17064129bd28724a.webp",980,1353]